Clinical Trial Update: Comparing ARNI With ACE Inhibitor on Endothelial Function [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing ARNI with ACE inhibitor on endothelial function in heart failure with reduced ejection fraction has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Heart Failure With Reduced Ejection Fraction | Phase 4 | Status: WITHDRAWN